Evidence map›Paper›PMID 16234238›Full record

ArticleThe Journal of biological chemistry2005

Two-dimensional kinetics regulation of alphaLbeta2-ICAM-1 interaction by conformational changes of the alphaL-inserted domain.

Fang Zhang, Warren D Marcus, Nimita H Goyal, Periasamy Selvaraj, Timothy A Springer, Cheng Zhu

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
3.4field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 72 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Single-molecule investigations of T-cell activation.Current opinion in biomedical engineering · 2019
    Article
  8. Cadherin Extracellular Domain Clustering in the Absence ofThe journal of physical chemistry letters · 2019
    Article
  9. Article
  10. The Journal of biological chemistry · 2017
    Article
  11. Article
  12. Article
  13. Article
  14. Mechanical regulation of T-cell functions.Immunological reviews · 2013
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Fang ZhangCoulter Department of Biomedical Engineering and Woodruff School of Mechanical Engineering, Georgia Institute of Technology, Atlanta, Georgia 30332, USA.
Warren D Marcus
Nimita H Goyal
Periasamy Selvaraj
Timothy A Springer
Cheng Zhu
Emory University · USThe Wallace H. Coulter Department of Biomedical Engineering · USGeorgia Institute of Technology · US

Funding

LYMPHOCYTE FUNCTION ASSOCIATED ANTIGENSR37CA031798 · NCI · IMMUNE DISEASE INSTITUTE, INC. · PI SPRINGER, TIMOTHY A · 2004 to 2013
$8.3M
Visualizing Single Integrin Conformational Changes on Living CellsR01AI044902 · NIAID · GEORGIA INSTITUTE OF TECHNOLOGY · PI ZHU, CHENG · 2000 to 2016
$5.8M
LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGENSR01CA031798 · NCI · IMMUNE DISEASE INSTITUTE, INC. · PI SPRINGER, TIMOTHY A · 1985 to 2018
$5.1M
Ligand Binding Kinetics and Cell Adhesion by Fc ReceptorR01AI038282 · NIAID · GEORGIA INSTITUTE OF TECHNOLOGY · PI ZHU, CHENG · 2001 to 2005
$1.9M
Regulation of CD32A in neutrophilsR01AI049400 · NIAID · EMORY UNIVERSITY · PI SELVARAJ, PERIASAMY · 2003 to 2007
$1.5M
Kinetic analysis of ligand binding by TCR and CD8R56AI038282 · NIAID · GEORGIA INSTITUTE OF TECHNOLOGY · PI ZHU, CHENG · 2012 to 2012
$389k
KINETIC PROPERTIES OF SELECTINSR21AI044902 · NIAID · GEORGIA INSTITUTE OF TECHNOLOGY · PI ZHU, CHENG · 2000 to 2000
$71k
LIGAND BONDING FORCE AND CELL ADHESION BY CD16 ISOFORMSR29AI038282 · NIAID · GEORGIA INSTITUTE OF TECHNOLOGY · PI ZHU, CHENG · 1995 to 1999
–
NCI NIH HHS CA31798NCI NIH HHS R01 CA031798NCI NIH HHS R37 CA031798NIAID NIH HHS AI049400NIAID NIH HHS AI38282NIAID NIH HHS AI44902NIAID NIH HHS R01 AI038282NIAID NIH HHS R01 AI044902NIAID NIH HHS R01 AI049400NIAID NIH HHS R21 AI044902NIAID NIH HHS R29 AI038282NIAID NIH HHS R56 AI038282
6 · The paper itself

Abstract

The leukocyte integrin alphaLbeta2 mediates cell adhesion and migration during inflammatory and immune responses. Ligand binding of alphaLbeta2 is regulated by or induces conformational changes in the inserted (I) domain. By using a micropipette, we measured the conformational regulation of two-dimensional (2D) binding affinity and the kinetics of cell-bound intercellular adhesion molecule-1 interacting with alphaLbeta2 or isolated I domain expressed on K562 cells. Locking the I domain into open and intermediate conformations with a disulfide bond increased the affinities by approximately 8000- and approximately 30-fold, respectively, from the locked closed conformation, which has similar affinity as the wild-type I domain. Most surprisingly, the 2D affinity increases were due mostly to the 2D on-rate increases, as the 2D off-rates only decreased by severalfold. The wild-type alphaLbeta2, but not its I domain in isolation, could be up-regulated by Mn2+ or Mg2+ to have high affinities and on-rates. Locking the I domain in any of the three conformations abolished the ability of divalent cations to regulate 2D affinity. These results indicate that a downward displacement of the I domain C-terminal helix, induced by conformational changes of other domains of the alphaLbeta2, is required for affinity and on-rate up-regulation.

Indexed as

AnimalsGlycosylphosphatidylinositolsHumansIntercellular Adhesion Molecule-1K562 CellsKineticsMiceProtein BindingProtein ConformationSurface Plasmon ResonanceGlycosylphosphatidylinositolsIntercellular Adhesion Molecule-1

Identifiers

PMID16234238
PMCPMC1475765
OpenAlexW2044037317

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.